ROYAL BANK OF CANADA - ANIKA THERAPEUTICS INC ownership

ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 167 filers reported holding ANIKA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.04 and the average weighting 0.1%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of ANIKA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$928,000
-29.6%
49,792
-1.7%
0.00%
Q2 2023$1,318,000
+1.6%
50,669
+12.1%
0.00%
Q1 2023$1,297,000
+50.6%
45,187
+55.5%
0.00%
Q4 2022$861,000
-9.1%
29,065
-27.0%
0.00%
Q3 2022$947,000
+4.4%
39,814
-2.0%
0.00%
Q2 2022$907,000
-7.8%
40,612
+3.5%
0.00%
Q1 2022$984,000
-35.8%
39,235
-8.2%
0.00%
Q4 2021$1,532,000
-15.2%
42,755
+0.7%
0.00%
Q3 2021$1,806,000
+1.0%
42,451
+2.7%
0.00%
Q2 2021$1,789,000
+7.5%
41,336
+1.4%
0.00%
Q1 2021$1,664,000
-28.6%
40,774
-20.8%
0.00%
-100.0%
Q4 2020$2,331,000
+30.8%
51,508
+2.3%
0.00%0.0%
Q3 2020$1,782,000
-5.4%
50,367
+0.9%
0.00%0.0%
Q2 2020$1,883,000
+34.5%
49,920
+3.0%
0.00%0.0%
Q1 2020$1,400,000
-41.3%
48,460
+5.4%
0.00%0.0%
Q4 2019$2,384,000
-10.5%
45,977
-5.3%
0.00%0.0%
Q3 2019$2,665,000
-14.4%
48,554
-36.7%
0.00%0.0%
Q2 2019$3,113,000
+102.5%
76,646
+50.8%
0.00%0.0%
Q1 2019$1,537,000
+7.3%
50,819
+19.3%
0.00%0.0%
Q4 2018$1,433,000
-24.1%
42,611
-4.8%
0.00%0.0%
Q3 2018$1,887,000
+41.8%
44,744
+7.6%
0.00%0.0%
Q2 2018$1,331,000
-45.1%
41,601
-14.7%
0.00%0.0%
Q1 2018$2,425,000
-3.7%
48,756
+4.3%
0.00%0.0%
Q4 2017$2,518,000
-8.4%
46,726
-1.4%
0.00%0.0%
Q3 2017$2,750,000
+39.5%
47,412
+18.7%
0.00%0.0%
Q2 2017$1,971,000
+12.2%
39,950
-1.2%
0.00%0.0%
Q1 2017$1,757,000
-4.9%
40,421
+7.0%
0.00%0.0%
Q4 2016$1,848,000
+4.4%
37,763
+2.1%
0.00%0.0%
Q3 2016$1,770,000
-14.0%
36,987
-3.5%
0.00%0.0%
Q2 2016$2,057,000
+76.1%
38,330
+46.8%
0.00%0.0%
Q1 2016$1,168,000
-19.1%
26,106
-31.0%
0.00%0.0%
Q4 2015$1,443,000
+20.7%
37,810
+0.5%
0.00%0.0%
Q3 2015$1,196,000
-2.9%
37,612
+0.8%
0.00%0.0%
Q2 2015$1,232,000
+10.3%
37,302
+37.5%
0.00%0.0%
Q1 2015$1,117,000
+5.0%
27,131
+3.8%
0.00%0.0%
Q4 2014$1,064,000
+71.9%
26,131
+54.9%
0.00%
Q3 2014$619,000
-19.7%
16,875
+1.4%
0.00%
-100.0%
Q2 2014$771,000
+11.6%
16,650
-0.9%
0.00%0.0%
Q1 2014$691,000
+10.4%
16,800
+2.4%
0.00%
Q4 2013$626,000
+63.4%
16,400
+2.6%
0.00%
Q3 2013$383,000
+32.5%
15,987
-6.0%
0.00%
Q2 2013$289,00017,0000.00%
Other shareholders
ANIKA THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Euclidean Technologies Management, LLC 44,875$2,031,0002.14%
Parian Global Management LP 102,705$4,648,0001.16%
CAPITAL MANAGEMENT CORP /VA 93,035$4,211,0001.15%
Avidity Partners Management LP 731,000$33,085,0001.07%
Sio Capital Management, LLC 65,382$2,959,0000.61%
DIKER MANAGEMENT LLC 21,835$988,0000.50%
Archon Capital Management LLC 48,925$2,214,0000.38%
Caption Management, LLC 362,800$16,420,0000.37%
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC 1,546,260$69,984,0000.20%
Boston Trust Walden Corp 378,167$17,116,0000.18%
View complete list of ANIKA THERAPEUTICS INC shareholders